Kvalito
Contact USLet’s find out how we can master your challenges
Get in Touch
Group Headquarters
Group
Headquarters
SwITZERLAND
Dornacherstrasse 101
CH-4053 Basel (Stadt)
Switzerland
Reg. ID: CHE-147.216.140
Phone: +41 794 614 744 Email: contact@kvalito.ch
Global Offices
UNITED STATES
KVALITO Inc.
8 The Green, Suite B
Dover, DE 19901
State Entity ID: 10702260
GERMANY
KVALITO Deutschland GmbH
Akademiestraße 2A
D-69117 Heidelberg
(Head Office Germany)
Clemensstr. 10
D-60487 Frankfurt a. M.
Company Registration No.: HRB 729936
Registration Court: Mannheim Local Court
Phone: +49 69 970 705 70
IRELAND
KVALITO Ireland Ltd.
The Black Church
St Mary’s Place, IE-Dublin 7
D07 P4AX
Company Registration No.: 569873
Phone: +353 86 142 6579
MAlaysia
KVALITO Malaysia Sdn Bhd
Suite 931, Level 9, Menara UAC, No. 12 Jalan PJU, 7/5, Mutiara Damansara, Selangor, 47800 Petaling Jaya
Company Registration No.: 202001038028 (1394349-M)
Phone: +6 122 509 052
Phone: +6 03 7666 5022
CZECH REPUBLIC
KVALITO Czech Republic S.R.O
Nad Primakov 250/10
Praha 10
CZ-100 00
Company Registration No.: IC 036 01 200
Phone: +420 234 092 520
SPAIN
KVALITO Iberia S.L.
Calle Del Conde de Aranda, 1–2º izda
28001 Madrid
Company Registration No. (NIF): B56178973
Phone: +34 91 564 64 32
ITALY
KVALITO Italy S.r.l.
Via Colico, 36 by A&B
20158 Milan (MI) by A&B
Company Registration No.: MI-2689511
Phone: +39 02 89 65 563 00
INdia
Life Science Tech KVALITO Private Limited
#Survey No. 199,
Vamsirams Jyothi Granules, Tower-1, 2nd Floor,
Kondapur Main Road,
Opp. Chirec School, Laxmi Nagar, Kondapur,
Hyderabad – 500084, Telangana
Company Registration No. (NIF): U70200TS2024FTC221632
Stay updated
OUR BLOG
Unlocking AI Opportunities in Regulatory Affairs
An approved promotional claim can raise new questions when it’s adapted for another market. Reviewers need to find supporting evidence, previous decisions and changing local requirements. Could AI make this process easier? A practical use case looks at where technology could help while keeping expert judgment at the centre.
From Validation to Cyber Resilience: What the EMA Annex 11 Draft Means for GxP Cybersecurity
Cybersecurity in GxP is no longer just an IT concern. This article explores how the draft EMA Annex 11 aligns with cybersecurity practices, what this means for governance and system lifecycle management, and steps pharmaceutical companies can take to strengthen resilience.
Do You Know Where AI Is Already Shaping GMP Decisions in Your Organization?
AI may already be shaping GMP decisions in your organization, even within familiar tools. This article explores how to identify where AI is used, distinguish trained models from programmed logic, and understand what draft Annex 11 and Annex 22 mean for…